| Market Capitalization (Millions $) |
859 |
| Shares
Outstanding (Millions) |
438 |
| Employees |
81 |
| Revenues (TTM) (Millions $) |
41 |
| Net Income (TTM) (Millions $) |
-61 |
| Cash Flow (TTM) (Millions $) |
4 |
| Capital Exp. (TTM) (Millions $) |
0 |
Business Description
Lexicon Pharmaceuticals Inc is a biopharmaceutical company that is focused on the discovery, development, and commercialization of innovative therapies for the treatment of various diseases. The company's mission is to improve patient lives by bringing breakthrough medicines to market.
The company was founded in 1995 and is headquartered in The Woodlands, Texas. It has a team of experienced professionals who have a track record of success in drug discovery and development, regulatory affairs, and commercialization.
Lexicon Pharmaceuticals has a diverse pipeline of drug candidates that are being developed for the treatment of various conditions such as diabetes, neuropathic pain, carcinoid syndrome, and irritable bowel syndrome. One of their most advanced drug candidates is sotagliflozin, which is a dual inhibitor of sodium-glucose cotransporter 1 and It is being developed as an adjunct to insulin therapy for type 1 diabetes and as a monotherapy for type 2 diabetes.
Another key drug candidate is telotristat etiprate, which is the first and only FDA-approved treatment for carcinoid syndrome diarrhea. The drug is also being developed for the treatment of refractory carcinoid syndrome and pulmonary arterial hypertension.
In addition to its robust pipeline of drug candidates, Lexicon Pharmaceuticals has strategic collaborations with pharmaceutical and biotech companies such as Sanofi, Ipsen, and Bristol-Myers Squibb. These collaborations provide additional resources and expertise to help the company advance its drug candidates and bring them to market.
Overall, Lexicon Pharmaceuticals is a well-established biopharmaceutical company with a strong commitment to developing innovative treatments for patients with unmet medical needs. Its strong pipeline and strategic collaborations position the company for continued growth and success in the future.
Company Address: 2445 Technology Forest Blvd. The Woodlands 77381 TX
Company Phone Number: 863-3000 Stock Exchange / Ticker: NASDAQ LXRX
|
255.78 %